News & Alerts
-
Dec- 2023 -7 December
Merck KGaA Faces Significant Setback as Multiple Sclerosis Drug Falters in Advanced Trials
Merck KGaA’s (MRCG.DE) growth ambitions have taken a significant hit as its experimental multiple sclerosis (MS) drug, evobrutinib, fell short…
Read More » -
6 December
Leal Health Leverages Generative AI to Optimize Cancer Treatment Matching for Patients
Leal Health, formerly known as Trialjectory, has unveiled a groundbreaking addition to its patient-centric, AI-powered treatment platform for cancer care.…
Read More » -
6 December
Global Acute Myeloid Leukemia (AML) Therapeutics Market Projected to Reach $1.6 Billion by 2030
The “Acute Myeloid Leukemia (AML) Therapeutics – Global Strategic Business Report” by ResearchAndMarkets.com reveals a robust growth projection for the…
Read More » -
6 December
ASOP Survey Reveals More Americans Buy Meds Online Despite Safety Risks
A recent survey commissioned by the Alliance for Safe Online Pharmacies (ASOP) Global Foundation highlights a significant increase in Americans…
Read More » -
6 December
Qilu Pharmaceutical Announces Results from Phase II Study for iparomlimab for Advanced Solid Tumors at ESMO Asia, with an ORR of 45.8%
Qilu Pharmaceutical presented the latest results of the single-arm, phase II pivotal clinical study for iparomlimab (QL1604), an innovative Class…
Read More » -
5 December
FDA Announces The Voluntary Recall of SoClean Equipment Intended for Use with CPAP Devices and Accessories
The U.S. Food and Drug Administration (FDA) is providing additional information about a product recall related to the use of…
Read More » -
5 December
STD Specialists Warn of Shortage of Vital Syphilis Drug, Bicillin L-A
By Ernie Mundell HealthDay Reporter As syphilis cases surge across America, a group representing the nation’s STD specialists says members are reporting shortages of…
Read More » -
5 December
Vanda Pharma’s New Drug Application for Tradipitant in Gastroparesis Accepted by FDA
Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has accepted the filing of…
Read More » -
5 December
Study Finds ChatGPT Provides Inaccurate Responses to Drug Questions
A recent study presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting has raised concerns about the accuracy…
Read More » -
4 December
AstraZeneca Embarks on AI-Powered Antibody-based Drug Discovery Journey with $247 Million Collaboration with Absci
AstraZeneca (AZ) has entered into a collaboration with US generative artificial intelligence (GenAI) company Absci, valued at up to $247…
Read More »